Breaking News
The Difference Between Us and Them
The Pentagon Has An Air Power Addiction
Trump's War on Iran Obstructs His Other Goals
America's 'Pilot Rescue' Happened 10km From Iran's Hidden Nuclear Weapons Stash
Top Tech News
DARPA O-Circuit program wants drones that can smell danger...
Practical Smell-O-Vision could soon be coming to a VR headset near you
ICYMI - RAI introduces its new prototype "Roadrunner," a 33 lb bipedal wheeled robot.
Pulsar Fusion Ignites Plasma in Nuclear Rocket Test
Details of the NASA Moonbase Plans Include a Fifteen Ton Lunar Rover
THIS is the Biggest Thing Since CGI
BACK TO THE MOON: Crewed Lunar Mission Artemis II Confirmed for Wednesday...
The Secret Spy Tech Inside Every Credit Card
Red light therapy boosts retinal health in early macular degeneration
Hydrogen-powered business jet edges closer to certification 
Tumor-Destroying Sound Waves Treatment Coming to a Hospital Near You For Liver Cancer
Known as "histotripsy," the method and machinery have already been tested successfully in animals and humans, and has just been approved for use by the FDA.
HistoSonics is a company founded in 2009 to create an ultrasound device that both screens for tumors and administers histotripsy. It was born from the efforts of scientists at the University of Michigan who co-founded the firm.
"Histotripsy is an exciting new technology that, although it is in early stages of clinical use, may provide a noninvasive treatment option for patients with liver cancer. Hopefully it can be combined with systemic therapies for a synergistic therapeutic effect," said Mishal Mendiratta-Lala, professor of radiology with Michigan Medicine.
Mendiratta-Lala was the principal investigator of an FDA human trial started in 2021 which confirmed that HistoSonic's device, called Edison, can destroy cancer tumors.